Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinoma

被引:25
|
作者
Liu, Hengrui [1 ]
机构
[1] Tianjin Yinuo Biomed Co Ltd, 1 Shuchang Pk,Wanxin St, Tianjin, Peoples R China
关键词
Cuproptosis; KIRC; Genes; Immunotherapy;
D O I
10.1016/j.cancergen.2023.03.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cuproptosis is a newly identified programmed cell death pathway mediated by intracellular free copper. Cuproptosis genes were studied in this study for a better insight into the role of cuproptosis in cancers. The analysis identified kidney renal clear cell carcinoma (KIRC) as a cancer type most likely to be affected by cuproptosis. This study analyzed the multi-omic data to explore the cancer-noncancer expression pattern and potential immune involvement of the cuproptosis pathway in KIRC. This study clustered the TCGA KIRC samples based on the gene set of 12 cuproptosis genes to study the role of cuproptosis in the KIRC immune microenvironment and found the potential value of cuproptosis signature for immunotherapy prognosis. This study concluded that cuproptosis might affect KIRC and had potential application value in immune therapy. Hopefully, this study can contribute to the application of cuproptosis in the clinical therapy of KIRC.& COPY; 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:21 / 25
页数:5
相关论文
共 50 条
  • [1] The potential of targeting cuproptosis in the treatment of kidney renal clear cell carcinoma
    Lei, Guojie
    Tang, Lusheng
    Yu, Yanhua
    Bian, Wenxia
    Yu, Lingyan
    Zhou, Junyu
    Li, Yanchun
    Wang, Ying
    Du, Jing
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 167
  • [2] Molecular subtypes based on cuproptosis regulators and immune infiltration in kidney renal clear cell carcinoma
    Liu, Aibin
    Li, Yanyan
    Shen, Lin
    Li, Na
    Zhao, Yajie
    Shen, Liangfang
    Li, Zhanzhan
    FRONTIERS IN GENETICS, 2022, 13
  • [3] Cuproptosis: A potential therapeutic target in clear cell renal cell carcinoma
    Zhao Yuetong
    Li Jie
    Lu Xiaojie
    Wu Shuang
    Xing Yunze
    Fang Yaxuan
    Yang Bo
    中华医学杂志英文版, 2024, 137 (11)
  • [4] Cuproptosis: A potential therapeutic target in clear cell renal cell carcinoma
    Zhao, Yuetong
    Li, Jie
    Lu, Xiaojie
    Wu, Shuang
    Xing, Yunze
    Fang, Yaxuan
    Yang, Bo
    CHINESE MEDICAL JOURNAL, 2024, 137 (11) : 1378 - 1380
  • [5] The signature genes of cuproptosis associates with tumor immune microenvironment and predicts prognosis in kidney renal clear cell carcinoma
    Liu, Shuhan
    Lv, Shijie
    Li, Xi
    Lu, Weiguo
    Chen, Shengjie
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [6] CRYL1 is a Potential Prognostic Biomarker of Clear Cell Renal Cell Carcinoma Correlated with Immune Infiltration and Cuproptosis
    Li, Peng
    Xu, Qiangqiang
    Liu, Ken
    Ye, Junjie
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [7] A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma
    Xin, Sheng
    Mao, Jiaquan
    Cui, Kai
    Li, Qian
    Chen, Liang
    Li, Qinyu
    Tu, Bocheng
    Liu, Xiaming
    Wang, Tao
    Wang, Shaogang
    Liu, Jihong
    Song, Xiaodong
    Song, Wen
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [8] Clinical significance and immune landscape of cuproptosis-related lncRNAs in kidney renal clear cell carcinoma: a bioinformatical analysis
    Li, Ding
    Wu, Xuan
    Song, Wenping
    Cheng, Cheng
    Hao, Lidan
    Zhang, Wenzhou
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (22)
  • [9] Cuproptosis-Related Ferroptosis genes for Predicting Prognosis in kidney renal clear cell carcinoma
    Luo, Gang
    Wang, Lini
    Zheng, Ziyu
    Gao, Baobao
    Lei, Chong
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [10] DLAT, as a Cuproptosis-Related Gene, Regulates Kidney Renal Clear Cell Carcinoma Progression
    Zhang, Peizhi
    Qiu, Jiechuan
    Wang, Qingliang
    Xu, Yingkun
    Wang, Zicheng
    Peng, Fan
    Hao, Yuhu
    Wu, Guangzhen
    Xia, Qinghua
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (03): : 1267 - 1283